#195 Can AI Unearth Stocks with 100x Growth Potential?

Stock Club - A podcast by MyWallSt - Thursdays

Categories:

Sign up now to be the first to learn about our groundbreaking AI-powered stock picking service, Nexus - https://mywallst.com/nexus/Welcome to episode #195 of Stock Club by MyWallSt, the podcast that delves into the intricacies of investing and finance.In this episode, we delve deep into the world of AI-enhanced investing, spotlighting MyWallSt's groundbreaking service, Nexus. Mike and Emmet discuss how Nexus, combining AI and human expertise, revolutionises stock selection with its unique blend of quantitative and qualitative analysis. We also explore the electric vehicle market, focusing on Tesla's success, and examine Camurus AB, a promising player in the pharmaceutical industry, so make sure you watch till the end!This episode is sponsored by Vodafone Business. V-Hub advisers are here to help you achieve your business goals. With specialisms across a range of digital skills, our advisers are ready to assist you with free support and guidance, so your business can thrive in the digital world.Check it out: https://r.vodafone.ie/v-hub-AdvisoryBecome a successful investor by checking out all the content MyWallSt has to offer:📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/🎉 Follow MyWallSt on social:🐦 Twitter: @MyWallSt 💃 TikTok: @MyWallSt 📸 Instagram: @MyWallSt🖥️ Facebook: @MyWallSt 👔 LinkedIn: MyWallSt(00:00) Preview(00:38) Tesla and the Future of The EV Industry(04:36) Nexus: MyWallSt’s AI Stock Picking Service(07:58) Exploring Nexus’ Potential (14:57) How Does Nexus Work?(24:06) Nexus’ Performance Against the Market(28:55) Nexus’ Best Performer?(31:57) Camurus: Pharma’s Next Big Bet?(34:09) Nexus’s Risk Management Strategy Hosted on Acast. See acast.com/privacy for more information.